SGMOQSANGAMO THERAPEUTICS, INC同业对比
SANGAMO THERAPEUTICS, INC 与Biological Products, (No Diagnostic Substances)的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Biological Products, (No Diagnostic Substances))| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGMOQ本股 | — | — | — | — | -31.6%#8 | -25.5%#8 | -306.5%#3 | — | — | — | — | — |
| MEOBF | — | — | — | — | 191.4%#3 | -16.1%#5 | — | — | — | — | — | — |
| MESO | $19.6B#2 | — | — | 1141.7x#2 | 191.4%#3 | -16.1%#5 | — | — | — | — | -4.3%#1 | — |
| MOLN | $155M#5 | — | — | — | — | — | — | — | — | — | -7.5%#3 | — |
| OKYO | $71M#6 | — | — | — | — | 72.0%#2 | — | — | — | — | -36.3%#6 | — |
| PROK | — | — | — | — | 1075.0%#1 | -12.7%#4 | -18477.8%#6 | — | — | — | -30.4%#4 | — |
| QGEN | $9.4B#3 | 22.3x#1 | 2.5x#1 | 4.5x#1 | 5.7%#7 | 408.3%#1 | 22.3%#1 | 11.2%#1 | 8.8%#1 | 7#1 | -4.7%#2 | 0.6%#1 |
| SCNI | $21.2B#1 | 381.2x#2 | 2610.9x#2 | 16137.4x#3 | 99.2%#5 | -273.2%#9 | -575.3%#4 | -102.5%#3 | -110.5%#3 | — | -90.3%#9 | — |
| SLBT | $2#7 | — | — | — | — | — | — | — | — | — | -83.1%#8 | — |
| TCRX | — | — | — | — | 266.7%#2 | -1.8%#3 | -1315.4%#5 | -188.0%#4 | -8271.2%#4 | — | -81.7%#7 | — |
| VALN | $1.1B#4 | — | — | — | — | — | — | — | — | — | -34.3%#5 | — |
| VISK | — | — | — | — | — | -538.2%#10 | -20426.9%#7 | -1.8%#2 | -1.7%#2 | — | — | — |
| ZEOX | — | — | — | — | 12.5%#6 | -17.3%#7 | -103.6%#2 | -775.4%#5 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-19。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议